About Endofotonics
Endofotonics is a company based in Singapore (Singapore) founded in 2014 by Cheng Tim Kum and Huang Zhi Wei. Endofotonics has raised $8.5 million across 2 funding rounds from investors including ZIG Ventures and Seeds Capital. Endofotonics operates in a competitive market with competitors including SamanTree Medical, Scholar Rock, Lightpoint Medical, Ionpath and Metrohm, among others.
- Headquarter Singapore, Singapore
- Founders Cheng Tim Kum, Huang Zhi Wei
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endofotonics Pte Ltd
-
Annual Revenue
Not available
-
Net Profit
-$1.37 M (USD)-28as on Jun 30, 2021
-
EBITDA
-$964.67 K (USD)-59as on Dec 31, 2019
-
Total Equity Funding
$8.5 M (USD)
in 2 rounds
-
Latest Funding Round
$8.5 M (USD), Series B
May 28, 2020
-
Investors
ZIG Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Endofotonics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Endofotonics
Endofotonics has successfully raised a total of $8.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.5 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endofotonics
Endofotonics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ZIG Ventures and Seeds Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ZIG Ventures is focused on healthcare innovation investments.
|
Locked | Locked | Locked | |
|
Nanotechnology-based battery solutions are provided via an online platform.
|
Locked | Locked | Locked |
Investor details for Endofotonics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endofotonics
Investment portfolio details for Endofotonics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endofotonics
Detailed financials for Endofotonics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endofotonics Comparisons
Peer comparison for Endofotonics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endofotonics
Endofotonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SamanTree Medical, Scholar Rock, Lightpoint Medical, Ionpath and Metrohm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A surgical digital microscope for tumor resection is developed.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| Locked | Locked | Locked |
Multiplexed ion beam imaging platform for tissue biopsies is developed.
|
|
| Locked | Locked | Locked |
Instruments for chemical analysis are developed and manufactured.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
Detailed competitors of Endofotonics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endofotonics
Complete news archive for Endofotonics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endofotonics
Endofotonics was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Endofotonics is headquartered in Singapore, Singapore.
Peter Cheng is the current CEO of Endofotonics.
Endofotonics is a funded company, having raised a total of $8.5M across 2 funding rounds to date.
Endophotonics is a medical device company that has developed an endoscopic system based on Raman Spectroscopy. The IMDX system consists of a Raman Spectroscope, a proprietary specially designed fibre-optic confocal Raman endoscopic probe that comprises a central light delivery fibre for laser light delivery and collection fibres for in vivo tissue Raman signal collection of tissue spectra and can be inserted into the instrument channel of conventional endoscopes and a proprietary control software that enables epithelial molecular information to be extracted and analyzed in real-time. Spectral information acquired by the system is matched against a database to quick diagnosis.
Endofotonics's top competitors include Scholar Rock, Ionpath and SamanTree Medical.
Endofotonics has 2 investors. Key investors include ZIG Ventures, and Seeds Capital.